Company news
Neuren Pharmaceuticals Limited news in 2018
Neuren Pharmaceuticals Limited's news releases, calls and decks from 2018, newest first.
Trofinetide ex-North America exclusive negotiation period
October 25, 2018
Neuren and Lanstead agree to pause settlements for 120 days
August 29, 2018
Neuren receives initial payment of US$10 million from ACADIA
August 22, 2018
Neuren and ACADIA announce agreement for North America
August 6, 2018
Announcement of buy-back - Appendix 3C
May 30, 2018
Neuren announces investment and exclusive negotiation period
May 20, 2018
First patent in Japan granted for Neurens trofinetide
April 29, 2018
Disclosure under Listing Rule 4.3D
March 29, 2018
S&P DJ Indices Announces March Quarterly Rebalance
March 8, 2018
Preliminary Final Report
February 28, 2018
Decks in 2018
- AusBiotech Invest and Partnering 2018
Conference · 11 slides · Nov 2, 2018
- Investor Presentation (September 2018)
Investor deck · 24 slides · Sep 6, 2018
- Corporate Update (August 2018)
Corporate update · 8 slides · Aug 7, 2018